AU1385701A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AU1385701A
AU1385701A AU13857/01A AU1385701A AU1385701A AU 1385701 A AU1385701 A AU 1385701A AU 13857/01 A AU13857/01 A AU 13857/01A AU 1385701 A AU1385701 A AU 1385701A AU 1385701 A AU1385701 A AU 1385701A
Authority
AU
Australia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13857/01A
Inventor
Barry Barton
Philip Andrew Greaves
Alison Michelle Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9925137.3A external-priority patent/GB9925137D0/en
Priority claimed from GBGB9925135.7A external-priority patent/GB9925135D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU1385701A publication Critical patent/AU1385701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
AU13857/01A 1999-10-22 2000-10-18 Novel compounds Abandoned AU1385701A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9925137.3A GB9925137D0 (en) 1999-10-22 1999-10-22 Novel compounds
GB9925135 1999-10-22
GBGB9925135.7A GB9925135D0 (en) 1999-10-22 1999-10-22 Novel compounds
GB9925137 1999-10-22
PCT/EP2000/010283 WO2001030977A2 (en) 1999-10-22 2000-10-18 5r clavam producing microorganisms with deleted lat and cvm genes

Publications (1)

Publication Number Publication Date
AU1385701A true AU1385701A (en) 2001-05-08

Family

ID=26316021

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13857/01A Abandoned AU1385701A (en) 1999-10-22 2000-10-18 Novel compounds

Country Status (4)

Country Link
EP (1) EP1228218A2 (en)
JP (1) JP2003512832A (en)
AU (1) AU1385701A (en)
WO (1) WO2001030977A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
GB0402799D0 (en) * 2004-02-09 2004-03-10 Sandoz Ag Pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9511679D0 (en) * 1995-06-09 1995-08-02 Smithkline Beecham Plc Novel process
GB9702218D0 (en) * 1997-02-04 1997-03-26 Smithkline Beecham Plc Novel product

Also Published As

Publication number Publication date
WO2001030977A3 (en) 2001-12-13
JP2003512832A (en) 2003-04-08
WO2001030977A2 (en) 2001-05-03
EP1228218A2 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
AU1278701A (en) Novel compounds
AU5413600A (en) Compounds
AU2001271434A1 (en) Novel skateboard-bicycle combination
AU4260199A (en) Novel compounds
AU2408300A (en) Novel compounds
AUPP999799A0 (en) New compound
AU1746401A (en) Compounds
AUPQ441499A0 (en) Novel compound
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU4814699A (en) Novel compounds
AU4132200A (en) Novel compounds
AU2359301A (en) Novel ss-defensins
AU2109700A (en) Novel compounds
AU2187799A (en) Novel taxaneterpine compounds
AU5787901A (en) Compound
AU6567400A (en) Substituted 2-imino-thiazolines
AU2288900A (en) Novel compounds
AU5119400A (en) Compounds
AU4156800A (en) Novel compounds
AU1385701A (en) Novel compounds
AU7784700A (en) Novel compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU6168900A (en) Compounds
AU2985200A (en) Novel sialoadhesins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 33, PAGE(S) 6983-6987 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 75227/00, 78164/00, 10160/01, 10334/01, 10338/01, 10347/01, 11443/01, 13857/01, 16923/01, 17382/01, 20196/01 AND 23014/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase